A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
About this item
Full title
Author / Creator
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
The COVID-19, caused by SARS-CoV-2, is threatening public health, and there is no effective treatment. In this study, we have implemented a multi-targeted anti-viral drug design strategy to discover highly potent SARS-CoV-2 inhibitors, which simultaneously act on the host ribosome, viral RNA as well as RNA-dependent RNA polymerases, and nucleocapsi...
Alternative Titles
Full title
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8076879
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8076879
Other Identifiers
ISSN
1671-4083,1745-7254
E-ISSN
1745-7254
DOI
10.1038/s41401-021-00668-7
